Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Genetic characterization of drug-induced Long QT Syndrome
2018-000564-28Phase 2Active
- Sponsor
- Hospital de la Santa Creu i Sant Pau Research Institute
- Start
- Mar 2018
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, single-arm trial of epinephrine in long QT syndrome (LQTS), sponsored by Hospital de la Santa Creu i Sant Pau Research Institute. Primary endpoint: Paradoxical QT response to epinephrine. Started Mar 2018; status: active.
02
Drugs
epinephrine
03
Conditions
long QT syndrome (LQTS)
Beyond the preview
Go deeper on 2018-000564-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-000564-28.